These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32188494)

  • 21. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway.
    Ji Y; Liu J; Wang Z; Li Z
    Cytokine; 2011 Sep; 55(3):409-19. PubMed ID: 21700474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.
    Haynes KR; Pettit AR; Duan R; Tseng HW; Glant TT; Brown MA; Thomas GP
    Arthritis Res Ther; 2012 Nov; 14(6):R253. PubMed ID: 23171658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of OCTN2 by cytokines plays an important role in the progression of inflammatory bowel disease.
    Li P; Wang Y; Luo J; Zeng Q; Wang M; Bai M; Zhou H; Wang J; Jiang H
    Biochem Pharmacol; 2020 Aug; 178():114115. PubMed ID: 32579962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease.
    Borniquel S; Jansson EA; Cole MP; Freeman BA; Lundberg JO
    Free Radic Biol Med; 2010 Feb; 48(4):499-505. PubMed ID: 19932165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway.
    Zhao Y; Wei X; Song J; Zhang M; Huang T; Qin J
    Inflammation; 2019 Jun; 42(3):841-856. PubMed ID: 30488141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Da Silva S; Keita ÅV; Mohlin S; Påhlman S; Theodorou V; Påhlman I; Mattson JP; Söderholm JD
    Inflamm Bowel Dis; 2018 Mar; 24(4):792-805. PubMed ID: 29529198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can we stop progression of ankylosing spondylitis?
    Schett G; Rudwaleit M
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):363-71. PubMed ID: 20534370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineral formation in joints caused by complete or joint-specific loss of ANK function.
    Gurley KA; Chen H; Guenther C; Nguyen ET; Rountree RB; Schoor M; Kingsley DM
    J Bone Miner Res; 2006 Aug; 21(8):1238-47. PubMed ID: 16869722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
    Omeragic A; Hoque MT; Choi UY; Bendayan R
    J Neuroinflammation; 2017 Sep; 14(1):183. PubMed ID: 28886715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner.
    Wei Z; Zhao D; Zhang Y; Chen Y; Zhang S; Li Q; Zeng P; Li X; Zhang W; Duan Y; Han J; Yang X
    Biochem Biophys Res Commun; 2019 Nov; 519(4):854-860. PubMed ID: 31561855
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Fredericks E; Dealtry G; Roux S
    Can J Gastroenterol Hepatol; 2018; 2018():4379673. PubMed ID: 30186819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPARγ attenuates LPS-mediated lung inflammation.
    Cho RL; Yang CC; Tseng HC; Hsiao LD; Lin CC; Yang CM
    Br J Pharmacol; 2018 Oct; 175(20):3928-3946. PubMed ID: 30088830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
    Venkataraman B; Ojha S; Belur PD; Bhongade B; Raj V; Collin PD; Adrian TE; Subramanya SB
    Phytother Res; 2020 Jul; 34(7):1530-1549. PubMed ID: 32009281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease.
    Luchetti MM; Ciccia F; Avellini C; Benfaremo D; Guggino G; Farinelli A; Ciferri M; Rossini M; Svegliati S; Spadoni T; Bolognini L; Fava G; Mosca P; Gesuita R; Skrami E; Triolo G; Gabrielli A
    J Rheumatol; 2018 May; 45(5):630-637. PubMed ID: 29419466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation.
    Cho RL; Lin WN; Wang CY; Yang CC; Hsiao LD; Lin CC; Yang CM
    Biochem Pharmacol; 2018 Feb; 148():222-237. PubMed ID: 29309760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model.
    Zhao J; Zhao R; Cheng L; Yang J; Zhu L
    Dig Liver Dis; 2018 Nov; 50(11):1195-1204. PubMed ID: 29891333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity.
    Sternes PR; Brett L; Phipps J; Ciccia F; Kenna T; de Guzman E; Zimmermann K; Morrison M; Holtmann G; Klingberg E; Mauro D; McIvor C; Forsblad-d'Elia H; Brown MA
    Arthritis Res Ther; 2022 Jul; 24(1):163. PubMed ID: 35794662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.